|
A roundup of FDA oncology news from September 2013
Oncology Nurse Advisor … agent is indicated for use in persons who have chronic lymphocytic leukemia (CLL) or who have indolent B-cell non-Hodgkin lymphoma that has progressed during or within 6 months of treatment with rituximab (Rituxan®) or a rituximab-containing regimen. |
Joint venture to tackle heart attacks in India, US launched – Economic Times
Economic TimesJoint venture to tackle heart attacks in India, US launchedEconomic TimesCHICAGO: Seeking to reduce the incidence of mortality from growing number of heart attacks in India and the US, a prominent body of Indian-American physicians has jo…
Heart transplant milestone at Vic hospital – Yahoo!7 News
|
Heart transplant milestone at Vic hospital
Yahoo!7 News Paediatric transplant surgery has come a long way since Dr Mee’s pioneering first transplant. Few know this better than Samantha McGowan, the mother of four-year-old transplant recipient Scarlett. In 2009 Scarlett was the recipient of Australia’s first … |
Delhi based College organizes Organ Donation Camp – Newstrack India
Newstrack IndiaDelhi based College organizes Organ Donation CampNewstrack IndiaAs a part of the Joy of Giving week (2nd Oct to 8th October), International College of Fashion, New Delhi organized an Organ Donation Camp on 1st October, 2013. It was aimed…
Biogen covers all bases for personalised approach to MS – PharmaTimes
|
Biogen covers all bases for personalised approach to MS
PharmaTimes Data is also being presented on Biogen’s investigational MS drugs, such as Plegridy (pegylated interferon beta-1a), the pegylated version of its older blockbuster Avonex and daclizumab, a once-monthly subcutaneous injection being developed with AbbVie. |
India and USA join hands to prevent heart attacks in both countries – India.Com Health
India and USA join hands to prevent heart attacks in both countriesIndia.Com HealthAn influential body of Indian American physicians and the American Heart Association (AHA) have joined hands to reduce the incidence of and deaths from heart attacks in …
Bondurant mom's mission: Cancer education – DesMoinesRegister.com
|
Bondurant mom’s mission: Cancer education
DesMoinesRegister.com Since that time he has undergone many rounds of chemotherapy and radiation treatment, a stem cell transplant and multiple surgeries. His treatments have taken him to hospitals across the state and beyond where he has spent countless hours in doctors’ … |
House Dem: 'I will not be donating or forgoing my salary' – Daily Caller
Daily Caller |
House Dem: ‘I will not be donating or forgoing my salary’
Daily Caller Wisconsin Democrat Rep. Gwen Moore has vowed that she will not give up her $174,000 congressional salary during the government shutdown. A large number of members from the Wisconsin delegation who have either refused to draw their federal salary … |
A joint venture to check heart attacks in India, US – Times of India
Economic TimesA joint venture to check heart attacks in India, USTimes of IndiaWASHINGTON: An influential body of Indian American physicians and the American Heart Association (AHA) have joined hands to reduce the incidence of and deaths from heart att…
Cellmid Limited receives federal research and development tax refund – Proactive Investors UK
Proactive Investors Australia |
Cellmid Limited receives federal research and development tax refund
Proactive Investors UK Recent studies have demonstrated that the company’s lead anti-midkine (MK) antibodies slowing primary tumour growth, reducing the spread of cancer and slowing the formation of blood vessels in different tumour types, which is a fundamental step in … CELLMID LIMITED : R&D Tax refund received4-traders (press release) |